National Comprehensive Cancer Network

|
|
|
|
For Patients
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

Clinical Recommendations

NCCN 3rd Annual Congress Hematologic Malignancies

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Congress Agenda

Satellite Symposia

Intended Audience

Accommodations

Registration Information

Accreditation

Commercial Support

Exhibiting

Refer a Friend


Go back to previous page

 

 

     
 

Educational Objectives

Following this program, participants should be able to:

  • List the appropriate pathology techniques for diagnostic and prognostic modeling for patients with hematologic malignancies
  • Identify the available therapeutic options for acute lymphocytic leukemia, cutaneous T-cell lymphoma, Hodgkin’s lymphoma, chronic myelogenous leukemia, and multiple myeloma
  • Describe the role of PET in the diagnosis and management of lymphomas
  • Define best practices for the management of supportive care issues with anemia and myelodysplastic syndromes
  • Compare and contrast the risks and benefits of using ESAs in cancer care
  • Recognize the challenges presented by advanced directives with advancing disease

Last update 03/17/2008.